137 related articles for article (PubMed ID: 36493725)
1. Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.
Bonfiglio F; Lasorsa VA; Cantalupo S; D'Alterio G; Aievola V; Boccia A; Ardito M; Furini S; Renieri A; Morini M; Stainczyk S; Westermann F; Paolella G; Eva A; Iolascon A; Capasso M
EBioMedicine; 2023 Jan; 87():104395. PubMed ID: 36493725
[TBL] [Abstract][Full Text] [Related]
2. Germline pathogenic variants in 786 neuroblastoma patients.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani N; Dymek M; Desai H; Hausler R; ; ; ; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
medRxiv; 2023 Jan; ():. PubMed ID: 36747619
[TBL] [Abstract][Full Text] [Related]
3. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.
Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY
BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452
[TBL] [Abstract][Full Text] [Related]
4. Identification of GALNT14 as a novel neuroblastoma predisposition gene.
De Mariano M; Gallesio R; Chierici M; Furlanello C; Conte M; Garaventa A; Croce M; Ferrini S; Tonini GP; Longo L
Oncotarget; 2015 Sep; 6(28):26335-46. PubMed ID: 26309160
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children.
Bae JS; Lee JW; Yoo JE; Joung JG; Yoo KH; Koo HH; Song YM; Sung KW
Cancer Res Treat; 2020 Oct; 52(4):1251-1261. PubMed ID: 32599975
[TBL] [Abstract][Full Text] [Related]
7. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract][Full Text] [Related]
8. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
9. Genetic predisposition and chromosome instability in neuroblastoma.
Tonini GP; Capasso M
Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
Altun Z; Yuan H; Baran B; Aktaş S; Sönmez EE; Küçük C; Olgun N
Gene; 2023 Apr; 860():147233. PubMed ID: 36736507
[TBL] [Abstract][Full Text] [Related]
11. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.
Bestetti I; Barbieri C; Sironi A; Specchia V; Yatsenko SA; De Donno MD; Caslini C; Gentilini D; Crippa M; Larizza L; Marozzi A; Rajkovic A; Toniolo D; Bozzetti MP; Finelli P
Hum Reprod; 2021 Oct; 36(11):2975-2991. PubMed ID: 34480478
[TBL] [Abstract][Full Text] [Related]
12.
Formicola D; Lasorsa VA; Cantalupo S; Testori A; Cardinale A; Avitabile M; Diskin S; Iolascon A; Capasso M
HGG Adv; 2023 Jan; 4(1):100158. PubMed ID: 36425957
[TBL] [Abstract][Full Text] [Related]
13. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
[TBL] [Abstract][Full Text] [Related]
14.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
bioRxiv; 2023 Feb; ():. PubMed ID: 36778420
[TBL] [Abstract][Full Text] [Related]
15. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
Romania P; Castellano A; Surace C; Citti A; De Ioris MA; Sirleto P; De Mariano M; Longo L; Boldrini R; Angioni A; Locatelli F; Fruci D
PLoS One; 2013; 8(10):e78481. PubMed ID: 24205241
[TBL] [Abstract][Full Text] [Related]
16. PHOX2B mutations and genetic predisposition to neuroblastoma.
Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
18. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
19. Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.
Egolf LE; Vaksman Z; Lopez G; Rokita JL; Modi A; Basta PV; Hakonarson H; Olshan AF; Diskin SJ
Am J Hum Genet; 2019 Sep; 105(3):658-668. PubMed ID: 31474320
[TBL] [Abstract][Full Text] [Related]
20. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
